THÔNG TIN TÀI LIỆU
hemodynamic effects of b-type natriuretic peptide and potentiates b-type natriuretic peptide effects in failing but not normal canine heart J Am Coll Cardiol 2007;49:1079–1088 49 Schrier RW Water and sodium retention in edematous disorders: role of vasopressin and aldosterone Am J Med 2006;119:S47–S53 50 Nielsen S, Terris J, Andersen D, et al Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct Proc Natl Acad Sci USA 1997;94:5450–5455 51 Martin PY, Abraham WT, Lieming X, et al Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure J Am Soc Nephrol 1999;10:2165–2170 52 Hauptman P, Kelly R Digitalis glycosides Hosenpud JD, Greenberg BH Congestive Heart Failure: Pathophysiology, Diagnosis and Comprehensive Approach to Management 2nd ed Lippincott Williams & Wilkins: Philadelphia; 2000:435–454 53 Ferguson DW, Berg WJ, Sanders JS, et al Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings Circulation 1989;80:65–77 54 The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 1997;336:525– 533 55 Uretsky BF, Young JB, Shahidi FE, et al Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial PROVED investigative group J Am Coll Cardiol 1993;22:955–962 56 Packer M, Gheorghiade M, Young JB, et al Withdrawal of digoxin from patients with chronic heart failure treated with angiotensinconverting-enzyme inhibitors RADIANCE study N Engl J Med 1993;329:1–7 57 Ahmed A, Bourge RC, Fonarow GC, et al Digoxin use and lower 30-day all-cause readmission for medicare beneficiaries hospitalized for heart failure Am J Med 2014;127:61–70 58 Yancy CW, Jessup M, Bozkurt B, Butler J, et al 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology Foundation/American heart association task force on practice guidelines Circulation 2013;128:e240–e327 59 Adams KF Jr, Gheorghiade M, Uretsky BF, et al Clinical benefits of low serum digoxin concentrations in heart failure J Am Coll Cardiol 2002;39:946–953 60 Rathore SS, Curtis JP, Wang Y, et al Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 2003;289:871–878 61 Kirk R, Dipchand AI, Rosenthal DN, et al The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary [corrected] J Heart Lung Transplant 2014;33:888–909 [Erratum in: J Heart Lung Transplant 2014 Oct;42(5):1104] 62 Berman W Jr, Yabek SM, Dillon T, et al Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect N Engl J Med 1983;308:363–366 63 Redington AN, Carvalho JS, Shinebourne EA Does digoxin have a place in the treatment of the child with congenital heart disease? Cardiovasc Drugs Ther 1989;3:21–24 64 Kimball TR, Daniels SR, Meyer RA, et al Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect Am ... 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology Foundation/American heart association task force on practice guidelines Circulation... Kirk R, Dipchand AI, Rosenthal DN, et al The international society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary [corrected] J Heart Lung Transplant 2014;33:888–909 [Erratum in: J Heart Lung
Ngày đăng: 22/10/2022, 12:13
Xem thêm: